NASDAQ:EBIO
Delisted

Eleven Biotherapeutics Fund Price (Quote)

$3.29
+0 (+0%)
At Close: May 31, 2018

Range Low Price High Price Comment
30 days $2.52 $3.50 Thursday, 31st May 2018 EBIO stock ended at $3.29. During the day the stock fluctuated 0% from a day low at $3.29 to a day high of $3.29.
90 days $0.90 $3.50
52 weeks $0.620 $3.50

Historical Eleven Biotherapeutics prices

Date Open High Low Close Volume
Nov 30, 2017 $0.660 $0.680 $0.645 $0.660 427 353
Nov 29, 2017 $0.690 $0.690 $0.648 $0.655 840 856
Nov 28, 2017 $0.700 $0.700 $0.660 $0.675 357 675
Nov 27, 2017 $0.698 $0.720 $0.670 $0.685 608 609
Nov 24, 2017 $0.650 $0.715 $0.630 $0.690 1 150 916
Nov 22, 2017 $0.661 $0.668 $0.630 $0.645 649 063
Nov 21, 2017 $0.700 $0.700 $0.651 $0.666 1 026 862
Nov 20, 2017 $0.740 $0.750 $0.665 $0.690 2 032 463
Nov 17, 2017 $0.675 $0.80 $0.670 $0.745 6 029 196
Nov 16, 2017 $0.672 $0.679 $0.648 $0.672 462 555
Nov 15, 2017 $0.650 $0.680 $0.640 $0.680 466 278
Nov 14, 2017 $0.670 $0.690 $0.650 $0.686 779 738
Nov 13, 2017 $0.683 $0.690 $0.663 $0.680 675 516
Nov 10, 2017 $0.698 $0.700 $0.620 $0.677 1 025 701
Nov 09, 2017 $0.735 $0.735 $0.680 $0.693 1 828 342
Nov 08, 2017 $0.690 $0.710 $0.660 $0.700 1 575 123
Nov 07, 2017 $0.730 $0.739 $0.650 $0.675 917 091
Nov 06, 2017 $0.773 $0.773 $0.710 $0.722 771 433
Nov 03, 2017 $0.730 $0.770 $0.720 $0.760 701 114
Nov 02, 2017 $0.738 $0.750 $0.710 $0.720 1 404 068
Nov 01, 2017 $0.88 $0.90 $0.690 $0.740 3 321 522
Oct 31, 2017 $1.01 $1.02 $0.92 $0.95 1 169 096
Oct 30, 2017 $1.09 $1.12 $1.00 $1.01 480 798
Oct 27, 2017 $1.07 $1.16 $1.06 $1.08 403 957
Oct 26, 2017 $1.20 $1.20 $1.07 $1.08 330 962
Click to get the best stock tips daily for free!

About Eleven Biotherapeutics

Eleven Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States. The company develops its therapeutics through AMP-Rx, a proprietary protein engineering platform. Its lead product candidate is EBI-005, which has completed Phase III clinical trials for the treatment of patients with dry eye disease and allergic conjunctivitis. The compa... EBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT